Kumar Erramilli, Chief Technology Officer, ACTO
Advertisement
Articles by Kumar Erramilli, Chief Technology Officer, ACTO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly’s Oral Weight Loss Pill Prescribed Over 1,000 Times in First Days on Market
2
Eli Lilly Releases Updated Safety Data for Foundayo Following FDA’s Request
3
Positioning A New Standard of Care in Relapsed Multiple Myeloma: Q&A with Imran Khan, MD, PhD
4
The Turning Point for Oral Biologics: Q&A With Morten Graugaard
5